Millions Logo
home>US Stocks>biote - Class A
BTMD
biote - Class AHealthcare
$1.03$-1.58 (-60.65%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $0.9952 Week High: $2.90

biote - Class A Share Price Today

biote - Class A opened at $1.09, in line with its previous close of $1.09. In the last trading session, the stock traded between $1.06 and $1.11. It showed a downward intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in biote - Class A is now worth

$ 16.24

Resulting in a loss of

$ 83.76 (83.76%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Hold

Rating from 1 Analysts

Buy
0%
Hold
100%
Sell
0%

Markets Today

Today's Change

$-0.07 (-5.96%)

Day High

$1.11

Day Low

$1.06

Day Open

$1.09

Prev Close

$1.09

Volume

1,00,579

1W Return

-16.33%

1M Return

-9.69%

3M Return

-33.01%

6M Return

-53.62%

1Y Return

-60.65%

Fundamentals

Market Cap ($ Mn)

29

PE Ratio

11.21

PB Ratio

-

PEG Ratio

0.41

ROE

-

ROCE

76.41%

EPS (TTM)

$0.02

Investment Returns

1 Week

-16.33%

1 Month

-9.69%

3 Months

-33.01%

6 Months

-53.62%

9 Months

-51.65%

Financials

Quarterly
All values in $ Mn
49.0

Mar 25
48.9

Jun 25
48.0

Sep 25
46.4

Dec 25
44.9

Mar 26
43.3

Sep 26

Updates

5Nov

Biote Q3FY26 Results: Revenue falls 9.6% to $43.3M, net income drops

Revenue fell 9.6% YoY to $43.3 million in Q3FY26. Procedure revenue declined 15.1% due to voluntary recall impacts. Net income dropped to $0.6 million from $9.2 million in Q3FY25. Full-year FY26 revenue guidance maintained at >$175 million.

8 days ago
22Oct

Biote Corp Q3FY26 Results: Earnings call set for Nov 4

Biote Corp schedules Q3FY26 earnings release for November 4, 2026. Conference call scheduled for 5:00 pm ET on the same day. Webcast replay available via investor relations website.

22 days ago
8Aug

TD Cowen Maintains Buy on Biote, Cuts Price Target to $2

TD Cowen analyst Jonna Kim maintains a Buy rating on Biote (NASDAQ: BTMD) but lowers the price target from $2.5 to $2. The move reflects a refined valuation model while preserving the positive long-term outlook for the biotechnology firm.

3mo ago
23Jul

Biote to announce Q2 2026 financial results on August 5

Biote will announce its Q2 2026 financial results on August 5, 2026, followed by a conference call at 5:00 p.m. ET. The company specializes in hormone optimization and healthy aging solutions.

3mo ago

Similar Stocks

StockLTPChange %Market CapPE
$506.04+0.32%$1,05,708.21M14.01
$304.77-0.26%$49,345.01M45.36
$292.97+0.93%$23,316.90M10.31
$72.62+0.18%$14,450.29M52.31
$79.43-1.38%$14,087.55M-
$142.24-0.19%$13,957.16M20.21
$22.22-2.29%$11,935.03M11.93
$183.50+2.35%$11,542.15M15.26
$186.19+0.59%$10,862.51M27.11
$196.77+0.70%$10,170.65M7.00
$103.03-0.49%$8,522.13M34.79
$50.06+1.96%$7,945.72M25.00